Charles River Laboratories International (CRL) Interest & Investment Income: 2009-2025
Historic Interest & Investment Income for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $1.4 million.
- Charles River Laboratories International's Interest & Investment Income fell 6.94% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 30.88%. This contributed to the annual value of $8.6 million for FY2024, which is 65.03% up from last year.
- As of Q3 2025, Charles River Laboratories International's Interest & Investment Income stood at $1.4 million, which was up 29.63% from $1.1 million recorded in Q2 2025.
- Charles River Laboratories International's Interest & Investment Income's 5-year high stood at $3.0 million during Q2 2024, with a 5-year trough of $35,000 in Q1 2021.
- Moreover, its 3-year median value for Interest & Investment Income was $1.4 million (2023), whereas its average is $1.6 million.
- As far as peak fluctuations go, Charles River Laboratories International's Interest & Investment Income slumped by 88.92% in 2021, and later skyrocketed by 1,025.41% in 2023.
- Charles River Laboratories International's Interest & Investment Income (Quarterly) stood at $309,000 in 2021, then grew by 11.00% to $343,000 in 2022, then spiked by 363.85% to $1.6 million in 2023, then increased by 15.34% to $1.8 million in 2024, then fell by 6.94% to $1.4 million in 2025.
- Its Interest & Investment Income was $1.4 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.4 million in Q1 2025.